Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma

Clinical trial NCT02406170 · COMPLETED

Trial details

NCT number: NCT02406170
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Neoplasms Stomach Neoplasms Neoplasm Metastasis

Start date: 2015-04-01
Primary completion: 2019-10-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.